Log in

Qiagen Stock Price, Forecast & Analysis (NYSE:QGEN)

$37.28
+1.83 (+5.16 %)
(As of 11/15/2019 04:34 AM ET)
Today's Range
$36.46
Now: $37.28
$37.57
50-Day Range
$25.45
MA: $30.17
$37.17
52-Week Range
$25.04
Now: $37.28
$41.55
Volume10.30 million shs
Average Volume1.36 million shs
Market Capitalization$8.41 billion
P/E Ratio27.82
Dividend YieldN/A
Beta0.83
QIAGEN N.V. provides sample to insight solutions that transform biological materials into molecular insights worldwide. The company offers sample technologies for plasmid deoxyribonucleic acid (DNA) purification, ribonucleic acid purification and stabilization, genomic and viral nucleic acid purification, DNA cleanup after polymerase chain reaction (PCR) and sequencing, target enrichment, and library preparation for sequencing applications; and assay technology solutions. Read More…

Industry, Sector and Symbol

Industry Biological products, except diagnostic
Sub-IndustryN/A
SectorMedical
CUSIPN/A
Phone31-77-355-6600

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.50 billion
Cash Flow$2.83 per share
Book Value$10.94 per share

Profitability

Net Income$190.38 million

Miscellaneous

Employees4,952
Market Cap$8.41 billion
Next Earnings Date2/3/2020 (Estimated)
OptionableOptionable

Receive QGEN News and Ratings via Email

Sign-up to receive the latest news and ratings for QGEN and its competitors with MarketBeat's FREE daily newsletter.


Qiagen (NYSE:QGEN) Frequently Asked Questions

What is Qiagen's stock symbol?

Qiagen trades on the New York Stock Exchange (NYSE) under the ticker symbol "QGEN."

How were Qiagen's earnings last quarter?

Qiagen NV (NYSE:QGEN) released its earnings results on Wednesday, October, 30th. The company reported $0.36 EPS for the quarter, topping analysts' consensus estimates of $0.35 by $0.01. The business earned $382.70 million during the quarter, compared to analysts' expectations of $382.98 million. Qiagen had a negative net margin of 1.68% and a positive return on equity of 12.24%. The company's quarterly revenue was up 1.3% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.35 earnings per share. View Qiagen's Earnings History.

When is Qiagen's next earnings date?

Qiagen is scheduled to release their next quarterly earnings announcement on Monday, February 3rd 2020. View Earnings Estimates for Qiagen.

What guidance has Qiagen issued on next quarter's earnings?

Qiagen issued an update on its FY19 earnings guidance on Wednesday, October, 30th. The company provided earnings per share guidance of $1.43-1.44 for the period, compared to the Thomson Reuters consensus estimate of $1.38. The company issued revenue guidance of ~$1.56 billion, compared to the consensus revenue estimate of $1.53 billion.

What price target have analysts set for QGEN?

16 analysts have issued 1 year target prices for Qiagen's shares. Their forecasts range from $25.00 to $42.00. On average, they anticipate Qiagen's share price to reach $33.83 in the next year. This suggests that the stock has a possible downside of 9.2%. View Analyst Price Targets for Qiagen.

What is the consensus analysts' recommendation for Qiagen?

16 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Qiagen in the last year. There are currently 8 hold ratings and 8 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Qiagen.

Has Qiagen been receiving favorable news coverage?

Press coverage about QGEN stock has been trending somewhat negative on Friday, according to InfoTrie Sentiment. InfoTrie identifies negative and positive media coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Qiagen earned a daily sentiment score of -1.4 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the stock's share price in the near term. View News Stories for Qiagen.

Are investors shorting Qiagen?

Qiagen saw a increase in short interest in the month of October. As of October 15th, there was short interest totalling 4,010,000 shares, an increase of 13.3% from the September 15th total of 3,540,000 shares. Based on an average daily trading volume, of 1,390,000 shares, the days-to-cover ratio is currently 2.9 days. Currently, 1.9% of the shares of the company are sold short. View Qiagen's Current Options Chain.

Who are some of Qiagen's key competitors?

What other stocks do shareholders of Qiagen own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Qiagen investors own include Netflix (NFLX), Gilead Sciences (GILD), NVIDIA (NVDA), Exelixis (EXEL), Twitter (TWTR), Cisco Systems (CSCO), QUALCOMM (QCOM), Boeing (BA), Activision Blizzard (ATVI) and Starbucks (SBUX).

Who are Qiagen's key executives?

Qiagen's management team includes the folowing people:
  • Mr. Peer Michael Schatz, CEO, MD & Member of Management Board (Age 53)
  • Dr. Roland Sackers, CFO, MD & Member of Management Board (Age 50)
  • Dr. Barthold Piening, Sr. VP & Head of Global Operations (Age 61)
  • Mr. John Gilardi, VP of Corp. Communications & Investor Relations
  • Mr. Jean-Pascal Viola, Head of Corp. Bus. Devel., Intellectual Property & Litigation and Sr. VP

Who are Qiagen's major shareholders?

Qiagen's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Massachusetts Financial Services Co. MA (5.55%), Hardman Johnston Global Advisors LLC (1.77%), First Trust Advisors LP (0.68%), Sycomore Asset Management (0.63%), Russell Investments Group Ltd. (0.22%) and Sector Gamma AS (0.21%).

Which major investors are selling Qiagen stock?

QGEN stock was sold by a variety of institutional investors in the last quarter, including First Trust Advisors LP, Assenagon Asset Management S.A., Hardman Johnston Global Advisors LLC, Exane Asset Management, Zurcher Kantonalbank Zurich Cantonalbank, Rhumbline Advisers, Crossmark Global Holdings Inc. and First Bank & Trust.

Which major investors are buying Qiagen stock?

QGEN stock was acquired by a variety of institutional investors in the last quarter, including Sycomore Asset Management, Massachusetts Financial Services Co. MA, Fisher Asset Management LLC, SG Americas Securities LLC, Sector Gamma AS, Russell Investments Group Ltd., Brinker Capital Inc. and Stephens Investment Management Group LLC.

How do I buy shares of Qiagen?

Shares of QGEN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Qiagen's stock price today?

One share of QGEN stock can currently be purchased for approximately $37.28.

How big of a company is Qiagen?

Qiagen has a market capitalization of $8.41 billion and generates $1.50 billion in revenue each year. The company earns $190.38 million in net income (profit) each year or $1.34 on an earnings per share basis. Qiagen employs 4,952 workers across the globe.View Additional Information About Qiagen.

What is Qiagen's official website?

The official website for Qiagen is http://www.qiagen.com/.

How can I contact Qiagen?

Qiagen's mailing address is HULSTERWEG 82, VENLO P7, 5912 PL. The company can be reached via phone at 31-77-355-6600 or via email at [email protected]


MarketBeat Community Rating for Qiagen (NYSE QGEN)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  188 (Vote Outperform)
Underperform Votes:  216 (Vote Underperform)
Total Votes:  404
MarketBeat's community ratings are surveys of what our community members think about Qiagen and other stocks. Vote "Outperform" if you believe QGEN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe QGEN will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/15/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel